article thumbnail

The Comprehensive Science and Art of Pharmaceutical Drug Naming

Drug Patent Watch

But what drives this complex system, and how do pharmaceutical companies ensure that their drug names meet the strict guidelines set by regulatory agencies? At the heart of pharmaceutical drug naming is the International Nonproprietary Name (INN) system. Share your thoughts in the comments below!

article thumbnail

Leadership evolution in India’s pharmaceutical sector in 2025- Driving global growth and innovation

Express Pharma

Continued strategic focus on North America: US market accounts for anywhere between 30 per cent to 60 per cent of annual revenues for Leading Pharmaceutical companies in India. Companies will continue to acquire leadership capabilities with focus on these markets.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ACI To Host Multiple Events Featuring HP&M Speakers – Discounts Available to FDA Law Blog Readers

FDA Law Blog: Biosimilars

FDA Law Blog readers can use discount code S10-866-866L24.S His practice supports clients throughout the life sciences from biotech startups and multinational pharmaceutical companies to CROs and academic researchers to patient advocacy organizations. More information about the conference can be found here.

article thumbnail

The Global Generic Drug Market: Trends, Opportunities, and Challenges

Drug Patent Watch

To learn more about the global generic drug market, including its trends, opportunities, and challenges, check out our latest blog post: [link] What do you think is the most significant challenge facing the global generic drug market? Share your thoughts in the comments below.

article thumbnail

Union Budget 2025-26: A roadmap for India’s pharmaceutical leadership

Express Pharma

It is therefore essential that the government revisits the 200 per cent weighted tax benefit on R&D spending in order to encourage more pharmaceutical companies to invest in innovative research. However, massive R&D expenditure is necessary to drive the next generation of discoveries.

article thumbnail

Beyond the Pill: Creating Value with Patient-Centric Pharmaceutical Marketing

Pharma Marketing Network

In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. Patient-centric pharmaceutical marketing is based on the understanding that patients are more than just consumers of drugs. It is also about changing the mindset of pharmaceutical companies.

article thumbnail

Healthware Group appoints Eugene Borukhovich as senior advisor

pharmaphorum

Prior to that, Eugene held pharmacy benefit management, consulting and pharmaceutical company leadership roles, with his most recent role being at Bayer where he led a global digital health team investing, partnering and building ventures.